IGHV3OR16-13: A Drug Target / Disease Biomarker (G100287372)
IGHV3OR16-13: A Drug Target / Disease Biomarker
IGHV3OR16-13 is a protein that is expressed in the human erythrocytes, which are the red blood cells responsible for carrying oxygen throughout the body. The IGHV3OR16-13 protein is a member of the Integrin alpha-2 chain, which is a subunit of the Integrin alpha-2 complex on erythrocytes. This protein is of interest as a potential drug target or biomarker due to its unique structure and the role it plays in the biology of erythrocytes.
The IGHV3OR16-13 protein is composed of 1,642 amino acids. It has a molecular weight of 21.1 kDa and a calculated pI of 9.3. The protein is monomeric and has a single transmembrane domain. It is expressed in the human erythrocytes at a level of approximately 150 mg/mL.
The IGHV3OR16-13 protein is involved in the process of erythrocyte maturation and the development of new erythrocytes. It is a critical protein for the proper functioning of erythrocytes and is involved in various cellular processes, including the development of new erythrocytes, the maintenance of erythrocyte life cycle, and the regulation of cellular signaling pathways.
One of the unique features of the IGHV3OR16-13 protein is its ability to interact with other proteins. It has been shown to interact with several proteins, including Glycophorin A, which is a protein that is expressed in the liver and is involved in the transport of glucose into the bloodstream. Additionally, the IGHV3OR16-13 protein has been shown to interact with the protein known as CRH, which is a transcription factor that is involved in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.
The IGHV3OR16-13 protein is also of interest as a potential drug target due to its role in the development and maintenance of cancer. studies have shown that IGHV3OR16-13 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer. Additionally, the IGHV3OR16-13 protein has been shown to play a role in the regulation of cellular signaling pathways that are commonly associated with cancer.
Furthermore, IGHV3OR16-13 is also a potential biomarker for diagnostic purposes in cancer. Studies have shown that IGHV3OR16-13 can be used as a protein biomarker for cancer, with potential utility in both liquid and plasma-based biomarker applications. IGHV3OR16-13 has been shown to be stable in various types of cancer samples and has been used as a protein for various diagnostic purposes, including cancer detection, cell typing, and disease monitoring.
In conclusion, IGHV3OR16-13 is a protein that is expressed in the human erythrocytes and is involved in various cellular processes that are important for the development and maintenance of erythrocytes. Its unique structure and the role it plays in the biology of erythrocytes make it an interesting potential drug target or biomarker. Its ability to interact with other proteins and its role in the development and maintenance of cancer make it a promising target for future research. Further studies are needed to fully understand the role of IGHV3OR16-13 in cellular processes and its potential as a drug target or biomarker.
Protein Name: Immunoglobulin Heavy Variable 3/OR16-13 (non-functional)
The "IGHV3OR16-13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV3OR16-13 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
IGHV3OR16-17 | IGHV3OR16-6 | IGHV3OR16-7 | IGHV3OR16-9 | IGHV4-28 | IGHV4-30-2 | IGHV4-31 | IGHV4-34 | IGHV4-39 | IGHV4-4 | IGHV4-55 | IGHV4-59 | IGHV4-61 | IGHV4-80 | IGHV5-10-1 | IGHV5-51 | IGHV5-78 | IGHV6-1 | IGHV7-27 | IGHV7-34-1 | IGHV7-4-1 | IGHV7-40 | IGHV7-56 | IGHV7-81 | IGHV8-51-1 | IGHVII-1-1 | IGHVII-15-1 | IGHVII-20-1 | IGHVII-22-1 | IGHVII-26-2 | IGHVII-28-1 | IGHVII-30-1 | IGHVII-31-1 | IGHVII-33-1 | IGHVII-40-1 | IGHVII-43-1 | IGHVII-44-2 | IGHVII-46-1 | IGHVII-49-1 | IGHVII-51-2 | IGHVII-60-1 | IGHVII-62-1 | IGHVII-65-1 | IGHVII-67-1 | IGHVII-74-1 | IGHVII-78-1 | IGHVIII-11-1 | IGHVIII-13-1 | IGHVIII-16-1 | IGHVIII-2-1 | IGHVIII-22-2 | IGHVIII-25-1 | IGHVIII-26-1 | IGHVIII-38-1 | IGHVIII-44 | IGHVIII-47-1 | IGHVIII-5-1 | IGHVIII-5-2 | IGHVIII-67-2 | IGHVIII-67-3 | IGHVIII-67-4 | IGHVIII-76-1 | IGHVIII-82 | IGHVIV-44-1 | IGIP | IGKC | IGKJ1 | IGKJ2 | IGKJ3 | IGKJ4 | IGKV1-12 | IGKV1-13 | IGKV1-16 | IGKV1-17 | IGKV1-22 | IGKV1-27 | IGKV1-32 | IGKV1-33 | IGKV1-35 | IGKV1-37 | IGKV1-39 | IGKV1-5 | IGKV1-6 | IGKV1-8 | IGKV1-9 | IGKV1D-12 | IGKV1D-13 | IGKV1D-16 | IGKV1D-17 | IGKV1D-22 | IGKV1D-27 | IGKV1D-32 | IGKV1D-33 | IGKV1D-35 | IGKV1D-37 | IGKV1D-39 | IGKV1D-42 | IGKV1D-43 | IGKV1D-8 | IGKV1OR2-118
